Brief: Blueprint Medicines posts Q2 revenue USD 57.6 million
02/08/2023 13:23
Aug 2 (Reuters) - Blueprint Medicines Q2 revenue USD 57.6 million vs. IBES estimate USD 45.5 million
Recent news on Blueprint Medicines
See all newsBrief: Sanofi Announces Extension Of Blueprint Tender Offer
Brief: Blueprint Medicines Announces Data Reinforcing Safety Profile Of Long-Term Ayvakit
U.S. STOCKS ON THE MOVE-Texas Instruments, Broadcom, Circle
UBS raises Blueprint Medicines' PT on Sanofi's up to $9.5 billion takeover deal
U.S. RESEARCH ROUNDUP-Biomea Fusion, GE Aerospace, P&G